Lathosterolosis, a Novel Multiple-Malformation/Mental Retardation Syndrome Due to Deficiency of 3β-Hydroxysteroid-Δ5-Desaturase  by Brunetti-Pierri, Nicola et al.
Am. J. Hum. Genet. 71:952–958, 2002
952
Report
Lathosterolosis, a Novel Multiple-Malformation/Mental Retardation
Syndrome Due to Deficiency of 3b-Hydroxysteroid-D5-Desaturase
Nicola Brunetti-Pierri,1,3,* Gaetano Corso,2,* Massimiliano Rossi,1 Paola Ferrari,5
Fiorella Balli,5 Francesco Rivasi,6 Ida Annunziata,4 Andrea Ballabio,3,4
Antonio Dello Russo,2 Generoso Andria,1 and Giancarlo Parenti1
Departments of 1Pediatrics and 2Biochemistry and Medical Biotechnology, Federico II University, 3Telethon Institute of Genetics
and Medicine, and 4Medical Genetics, Second University of Naples, Naples; and Departments of 5Pediatrics and 6Pathology,
University of Modena, Modena, Italy
We report the clinical, biochemical, and molecular characterization of a patient with a novel defect of cholesterol
biosynthesis. This patient presented with a complex phenotype, including multiple congenital anomalies, mental
retardation, and liver disease. In the patient’s plasma and cells, we found increased levels of lathosterol. The
biosynthesis of cholesterol in the patient’s fibroblasts was defective, showing a block in the conversion of lathosterol
into 7-dehydrocholesterol. The activity of 3b-hydroxysteroid-D5-desaturase (SC5D), the enzyme involved in this
reaction, was deficient in the patient’s fibroblasts. Sequence analysis of the SC5D gene in the patient’s DNA,
showing the presence of two missense mutations (R29Q and G211D), confirmed that the patient is affected by a
novel defect of cholesterol biosynthesis.
Human malformations are usually caused by mutations
in genes that regulate embryonic patterning. Recently, in-
born errors of cholesterol biosynthesis emerged as another
cause of human malformations. Progress in this field was
marked by the identification of the metabolic and molec-
ular bases of well-known clinical entities, formerly clas-
sified as dysmorphogenetic syndromes, and by the redefi-
nition of these disorders as inborn errors of metabolism
(Opitz 1999; Kelley andHennekam 2000). The prototype
for this group of disorders is Smith-Lemli-Opitz (SLO)
syndrome (MIM 270400), in which mental retardation
is associated with major malformations that involve vir-
tually all organs and systems. This disease, caused by 7-
dehydrocholesterol reductase deficiency (Irons et al. 1993;
Fitzky et al. 1998; Wassif et al. 1998; Waterham et al.
1998), is characterized by high blood levels of specific
metabolites of postsqualene cholesterol biosynthesis. The
identification of the metabolic and molecular bases of
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SLO syndrome led to the discovery of other defects of
cholesterol biosynthesis. At present, recognized disorders
of this biochemical pathway include X-linked dominant
chondrodysplasia punctata (CDPX2 [MIM 302960]; also
known as “Conradi-Hunermann syndrome”), caused by
sterol D8,D7 isomerase deficiency (Braverman et al. 1999;
Kelley et al. 1999); X-linked dominant congenital hemi-
dysplasia with ichthyosis and limb defects (CHILD) syn-
drome (MIM 308050), caused by defective sterol C4 de-
methylase (Konig et al. 2000); and autosomal recessive
desmosterolosis (MIM 602398), caused by 3b-hydroxy-
sterol D24-reductase deficiency (Waterham et al. 2001).
Defects of cholesterol biosynthesis have been proposed in
autosomal recessive Greenberg dysplasia (MIM 215140),
which is likely due to sterol C14 reductase deficiency (Kel-
ley 2000), and in FGFR2-negative patients with Antley-
Bixler syndrome (MIM 207410), which is likely due to
defective lanosterol 14-a-demethylase (Kelley et al. 2002).
The cholesterol biosynthesis pathway in mammals is
complex, involving19 enzymatic steps, beginningwith
the condensation of acetyl-CoA to form mevalonate,
which in turn is converted into squalene. In the postsqua-
lene pathway, lanosterol originates from the cyclization
of squalene. Cholesterol is produced from lanosterol
through several multienzymatic reactions, including two
demethylations, an isomerization, a desaturation, and
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Figure 1 Cholesterol biosynthetic pathway—schematic represen-
tation of themain 27-carbon sterol intermediates derived from30-carbon
lanosterol. Enzymatic defects associated with the distal Kandutsch-
Russell pathway have already been described in human and mouse.
Desaturation of the C5 bond may occur at two different steps in the
pathway: 7-dehydrocholesterol is generated from the action of C5
sterol desaturase on lathosterol (cholest-7-en-3b-ol); this enzyme also
acts on zymostenol (cholest-8[9]-en-3b-ol), generating 8-dehydrocho-
lesterol. The enzymatic steps shown are as follows: (1) 3b-hydroxy-
steroid-D7-reductase (7-dehydrocholesterol reductase; E.C. 1.3.1.21),
defective in SLO syndrome; (2) 3b-hydroxysteroid-D8,D7-isomerase
(zymostenol isomerase; E.C. 5.3.3.5) defective in CDPX2 and tattered
mouse; (3) C3 sterol dehydrogenase (NSDHL) defective in bare patches
mouse and CHILD syndrome; and (4) SC5D.
three double-bond reductions (fig. 1). It is possible that
each step in this pathway can be defective and involved
in human disease. A challenge for clinicians and molec-
ular biologists is to identify “candidate” syndromes for
or patients with this group of disorders.
We have observed a proband with a complex phe-
notype, including multiple congenital anomalies, mental
retardation, and liver disease, who was affected by a
new defect of cholesterol biosynthesis. The proband was
born to healthy nonconsanguineous parents. Hermother
previously had two pregnancies: The first ended with the
abortion of a female fetus at 22 wk gestation, because
of multiple malformations that were revealed by a rou-
tine ultrasound scan and included microcephaly, lum-
bosacral myelomeningocele, hexadactyly of hands and
feet, and bilateral clubfoot; a standard karyotype of fetal
amniocytes was normal (46,XX). The second siblingwas
an unaffected male child.
The proband’s mother’s pregnancy was characterized
by poor maternal weight gain (4,000 g) and gestational
hypertension. Maternal serology for Toxoplasma, cyto-
megalovirus, herpesvirus, and rubella was negative. The
proband was born at 42 wk gestation, by spontaneous
delivery. Birth weight was 3,000 g (10th–25th percentile),
length was 48 cm (10th percentile) and occipitofrontal
circumference was 30 cm (!5th percentile).
Neonatal jaundice was treated with phototherapy.
Physical examination at birth revealed dysmorphic fea-
tures, including severe microcephaly, receding forehead,
anteverted nares, micrognathia, prominent upper lip,
high arched palate, postaxial hexadactyly of the left foot
(fig. 2A), and syndactyly between the 2nd–4th toes and
between the 5th toe and the extra digit. External geni-
talia were normal. Axial hypotonia and a fracture of the
right clavicle were also present. Neither ichthyosis nor
chondrodysplasia punctata were detectable. Biochemical
signs of abnormal liver function were detected during
the 1st year of life (aspartate aminotransferase 262–310
U/liter, alanine aminotransferase 188–218 U/liter, g-glu-
tamyl transpeptidase 539–639 U/liter, alkaline phospha-
tase 1,362–1,731 U/liter, total bilirubin 2.47 mg/dl, and
conjugated bilirubin 1.73 mg/dl). Viral infections, im-
mune diseases, and cystic fibrosis were excluded. Blood
cholesterol was 130 mg/dl. A standard karyotype and
metabolic screening tests were normal. A liver biopsy,
performed at age 14 mo, showed intrahepatic cholestasis
with irregular bile ducts and cholangiolitis with mild
granulocyte infiltration and diffuse expression in peri-
portal hepatocytes of biliary cytokeratin; no signs of
intracellular lipid storage were seen. Treatment with oral
ursodeoxycholic acid was started.
Severe psychomotor delay became increasingly evident
with age. Social smiling and interactions were extremely
poor. At age 2 years, the facial dysmorphism had grad-
ually changed, resembling that of SLO syndrome (fig. 2B).
An ultrasound scan of the abdomen showed a bilobate
gallbladder and mild left pyelectasis, and an x-ray survey
of the skeleton showed a cleft of the 8th thoracic vertebra.
Conductive deafness was found at the auditory evoked
potentials. Brain magnetic resonance imaging was normal.
At age 2 years, the proband was screened for SLO
syndrome, by use of a validated gas chromatography/mass
spectrometry (GC/MS) method (Corso et al. 2002) for
plasma sterol profile. The analysis showed no 7-dehydro-
cholesterol, whereas a peak corresponding to cholest-7-
en-3b-ol (lathosterol) (fig. 3) and representing 6.69% of
total plasma sterols was clearly detectable. Trace amounts
of lathosterol precursors—tentatively identifiedas cholest-
8(9)-en-3b-ol, 4-methylcholest-8(9)-en-3b-ol, and 4,4-di-
methylcholest-8(9)-en-3b-ol—were also found (table 1).
Sterol profile was performed in control plasma and cells,
for comparison. In the analysis, possible interference due
to cholestasis and ursodeoxycholic acid treatment was
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Figure 2 Lathosterolosis phenotype. A, Postaxial hexadactyly of the left foot, with syndactyly between the 2nd–4th toes and between
the 5th toe and the extra digit. B, Proband at age 3 years. Facial dysmorphisms include microcephaly, micrognathia, bilateral epicanthus, broad
nasal bridge with anteverted nares, long philtrum, thin lips with prominent upper lip, and ogival palate.
excluded by the examination, under the same conditions,
of two patients affected by Alagille syndrome (MIM
118450), two cholestatic patients treatedwith ursodeoxy-
cholic acid, and two patients who had received liver trans-
plants andwere treatedwith ursodeoxycholic acid, aswell
as by the repetition of the GC/MS sterol profile in the pro-
band’s plasma after discontinuation of therapy for 2 wk.
Sterol profiling of red cell membranes and fibroblasts,
cultured in delipidated medium for 15 d, resulted in the
same abnormal pattern (table 1). A slight increase of
lathosterol was found in the parents’ plasma (table 1)
and red cell membranes (not shown).
Cholesterol biosynthesis in the proband’s fibroblasts
was studied according to the method of Honda et al.
(1995), and the results were compared to those obtained
in control and SLO syndrome cell lines. Fibroblasts were
cultured in delipidated medium for 3 d; 3H-mevalonate,
an early intermediate of cholesterol biosynthesis,was then
added to the medium; and, after 3 d, fibroblasts were
harvested and extracted with a chloroform/metanol (2/1
v/v) mixture. The extracted sterols were separated by
AgNO3 silica thin-layer chromatography (TLC), with a
chloroform/acetone (96.5/3.5 v/v) mixture as solvent.
When cholesterol and lathosterol were not sufficiently re-
solved, a second TLC separation was run, with a diethyl
ether/hexane (5/1 v/v) mixture as solvent. The spots cor-
responding to cholesterol, lathosterol, and 7-dehydrocho-
lesterol were scraped, and radioactivity was measured.
The proband’s cells accumulated lathosterol (66.1% of
the recovered radioactivity), whereas SLO syndrome fi-
broblasts showed accumulation of 7-dehydrocholesterol
(78.2%). In control fibroblasts, 3H-mevalonate was nor-
mally converted to cholesterol (84.0%) (fig. 4). These re-
sults suggested a block in cholesterol biosynthesis at the
level of 3b-hydroxysteroid-D5-desaturase (SC5D [E.C.
1.3.3.2]; also known as “lathosterol dehydrogenase”).
SC5D is an enzyme that catalyzes a dehydrogenation re-
action introducing a C5-C6 double bond into lathosterol.
We measured SC5D enzymatic activity in fibroblasts
cultured in delipidated medium (Kelley 1995), according
to the method described by Taton et al. (2000). In brief,
fibroblast extracts containing 200 mg protein in 0.1 M
phosphate buffer (pH 7.5) with 3 mM reduced gluta-
thione and 20% glycerol were incubated for 90 min at
37C with 3H-lathosterol emulsified in Tween 80 (1.5 g/
liter), with the addition of 500 mM reduced nicotinamide
adenine dinucleotide. The incubation volume was 200
ml. The reaction was stopped with 6% KOH in ethanol
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Figure 3 Sterol profiles in proband with lathosterolosis. Typical
GC/MS analysis of plasma from the proband (top) and from an unaf-
fected control individual (bottom). The compounds definitively identified
are as follows: (1) internal standard (5a-cholestane); (2) cholesterol;
(3) zymostenol (cholest-8[9]-en-3b-ol); (4) lathosterol (cholest-7-en-3b-
ol). The compounds tentatively identified are as follows: (5) 4-methyl-
cholest-8[9]-en-3b-ol; and (6) 4,4-dimethylcholest-8[9]-en-3b-ol.
and was extracted with hexane. The different sterols
were separated on an AgNO3 silica TLC, as indicated
above. The spots corresponding to the separated sterols
were scraped, were extracted with hexane, and were
counted on a b-counter. The SC5D activity in the pro-
band’s fibroblasts was defective in four separate experi-
ments ( pmol/mg protein/min), as compared to10 12
that of control cell lines ( pmol/mgprotein/min).104 27
Cloning and sequencing of genes that encode SC5D
have been reported in a number of organisms, such as
Saccharomyces cerevisiae, Arabidopsis thaliana, Candida
glabrata, and C. albicans (Arthington et al. 1991; Geber
et al. 1995; Gachotte et al. 1996; Miyazaki et al. 1999).
The human SC5D cDNAwas cloned from a human brain
library as a sequence homologous to yeast enzyme, com-
plementing SC5D-deficient yeast mutant cells (Matsushi-
ma et al. 1996). The human SC5D gene is composed of
five exons (Sugawara et al. 2001) and maps to 11q23.3
(Nishi et al. 2000; Sugawara et al. 2001). Hydropathy
analysis of SC5D suggests that the enzyme is an integral
membrane protein with four to five membrane-spanning
regions (Kyte et al. 1982).
We looked for mutations in the SC5D gene in the pro-
band described herein. Sense and antisense oligonucleo-
tide primers, corresponding to intronic sequences flanking
the SC5D coding exons, were synthesized and were used
to amplify exons and their intronic junctions of genomic
DNA from the proband and her relatives. AmplifiedDNA
products were checked on agarose gel and were then se-
quenced bidirectionally on an ABI 377 automated DNA
sequencer.
We found two missense mutations in the proband’s
DNA, a 88GrA transversion that changes a basic amino
acid (arginine) into a neutral amino acid (glutamine) at
codon 29 in exon 1 (R29Q) and a 632 GrA transversion
that changes a glycine into an aspartic acid at codon 211
in exon 4 (G211D). Each parent was heterozygous for
one of the two mutations (R29Q, in the mother, and
G211D, in the father), indicating that the proband is a
compound heterozygote and suggesting that the disease
has an autosomal recessive pattern of inheritance. The
proband’s unaffected brother was heterozygous for the
R29Q mutation. To exclude the possibility that the mu-
tations found are common polymorphisms among the
general population, we analyzed, by denaturing high-per-
formance liquid chromatography, PCR-amplified prod-
ucts that corresponded to exons 1 and 4, in 50 unaffected
subjects, using the Wave DNA-fragment–analysis system
(Transgenomic). The mutations were not present in the
100 alleles screened.
Cholesterol biosynthesis defects, characterized by the
accumulation of specific metabolic precursors in blood
and tissues, have been increasingly implicated in human
malformation syndromes. The proband described herein
represents the first example of a new entry in this group
of disorders. The profiling, by GC/MS, of plasma and
cell sterols in the proband and studies of cholesterol
biosynthesis in cultured fibroblasts suggested a meta-
bolic block in the conversion of lathosterol into 7-de-
hydrocholesterol. SC5D deficiency in the proband was
confirmed by direct enzymatic assay in fibroblasts.
Mutational analysis in the proband’s DNA showed
two missense mutations of the SC5D gene. The finding
of defective SC5D in fibroblasts strongly suggests that
these mutations affect SC5D catalytic activity. One of
the mutations (G224D) changes an amino acid, close to
one of three histidine-rich regions of the SC5D protein,
that is highly conserved throughout phylogenesis. These
histidine-rich motifs are found in an important class of
integral membrane enzymes that includes desaturases,
hydroxylases, acetylenases, and epoxygenases. Histi-
dine-rich motifs are conserved among mammals, yeasts,
and plants and are likely involved in the formation of
a presumed catalytic Fe center, where oxygen activation
and substrate oxidation occur (Shanklin et al. 1994). In
A. thaliana, site-directed mutagenesis of these residues
abolished enzyme activity (Taton et al. 2000).Mutations
in this region are expected to affect enzyme activity. The
other mutation found is in a nonconserved residue lo-
cated outside the membrane, as predicted by hydropathy
analysis, and changes a strong basic amino acid into a
neutral residue.
Although there is no formal proof that the metabolic
derangement is causative of the phenotype observed in
the proband whom we studied, similarities with other
known defects of cholesterol biosynthesis make this hy-
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Figure 4 Cholesterol biosynthesis in control, lathosterolosis, and
SLO fibroblasts. The percentage of recovered radioactivity is reported
(mean  SD of three different experiments). In control fibroblasts,
of the incorporated radioactivity was recovered in the84.0% 18%
cholesterol fraction; in SLO fibroblasts, of the radio-78.2% 1.6%
activity was present as 7-dehydrocholesterol, and of14.0% 1.8%
the radioactivity was present as lathosterol. In the proband, of the
total radioactivity, cholesterol represented , 7-dehy-30.0% 11.0%
drocholesterol represented , and lathosterol represented3.4% 2.9%
.66.1% 10%
pothesis very likely. The appearance of the proband and
the presence of hexadactyly and liver disease (occasionally
reported in patients with SLO syndrome) are particularly
indicative in this respect. Lathosterol levels observed in
the proband described herein ( mg/dl) are13.04 2.65
comparable to 7-dehydrocholesterol levels observed inpa-
tients with SLO syndrome ( mg/dl, in 11 pa-13.8 6.4
tients analyzed in our laboratory). It is interesting that an
enzymatic block immediately upstream from 7-dehydro-
cholesterol reductase, as observed in the proband, results
in a phenotype more similar to that of SLO syndrome
than to the phenotypes observed in defects that involve
earlier steps of cholesterol biosynthesis. Additional evi-
dence that the phenotype observed in the proband is the
result of SC5D deficiency derives from the recent devel-
opment of a murine model of SC5D deficiency, showing
perinatal lethality, micrognathia, intrauterine growth re-
tardation, palatoschisis, short limbs, syndactyly, postaxial
hexadactyly, and hepatomegaly (Krakowiak et al. 2001).
The severe phenotype observed in the knockout mouse is
likely due to a complete disruption of the SC5D gene. In
the proband described herein, we found normal plasma
cholesterol levels and reduced synthesis of cholesterol in
fibroblasts incubated with 3H-mevalonate (30% of re-
covered radioactivity), suggesting residual SC5D catalytic
activity.
The relationships between abnormal cholesterol me-
tabolism and disturbed morphogenesis have been exten-
sively studied in recent years, bringing to the attention of
geneticists and dysmorphologists a new research field,
“metabolic morphogenesis” (Kelley 1998). An increasing
number of studies has implicated cholesterol in the hedge-
hog embryonic-signaling pathway (Opitz 1999; Kelley et
al. 2000). It has been shown that covalent attachment of
cholesterol to Sonic hedgehog (Shh) is essential for the
posttranslational autoprocessing of Shh into the mature
and active N-terminal polypeptide—for the correct lo-
calization of this peptide in membranes and for the in-
teractions with the sterol-sensing domain in Patched-1
and -2 (Villavivencio et al. 2000), two transmembrane
receptor proteins that regulate signal transduction. Mu-
tations of genes that encode other Shh pathway members
acting downstream from signal transduction are also im-
plicated in human disease and are associated with birth
defects and cancer (Villavivencio et al. 2000).
The hypothesis that malformations in SLO syndrome
and in related defects stem from abnormal functioning of
the Shh pathway is attractive; however, several points
need further investigation. It has been questionedwhether
cholesterol deficiency or increased levels of intermediate
sterols are responsible for the abnormal functioning of
the pathway (Kelley 1998) in SLO syndrome. Several lines
of evidence support the role that cholesterol deficiency
plays in causing malformations. The normal plasma cho-
lesterol found in the proband described herein should be
considered carefully, since it might not reflect cholesterol
concentration in rapidly growing cells during the embry-
onic period.
In conclusion, our data implicate SC5D deficiency in
human disease and extend the range of cholesterol bio-
synthesis defects that cause disturbed morphogenesis.
The precise definition of the phenotype that results from
SC5D deficiency has an impact on clinical practice, since
it may provide additional indications for biochemical
and molecular screening of patients with unexplained
malformations and since it allows prenatal diagnosis of
this disease. A precise clinical characterization of pa-
tients also enables the improvement of our understand-
ing of the interactions between specific metabolic blocks
and Shh and related proteins.
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